News

Huvepharma introduces Lianol, a fermented potato protein, with pro-metabolic activity

22.01.2010 | General News

PRESS RELEASE

Antwerp, January 2010

 

 

 

Natural proteins dictating the future

Huvepharma is a young, ambitious world player on the market of veterinary products and feed additives who regularly brings innovations and product introductions.  It has gained a strong position in the demanding segment of intensive live stock production thanks to its dedication and high quality products.

The intensive live stock production has changed dramatically over the years and farmers and integrators are continuously looking for possibilities to improve health status and production levels through clever use of new management systems and feed supplements.  Various reputable scientists strongly believe in the positive effects natural products can have on metabolic processes.  Reaching improved immunity levels results in higher health status and inherently means reaching higher productivity levels.  A large number of natural complementary feeding stuff products have been screened over the years but only a limited selection can deliver and live up to these expectations.  Huvepharma is introducing a perfect example of such a product, Lianol®, a highly digestible fermented potato protein of which the use results in pro-metabolic peptides in food producing animals.  Lianol® was developed by Ardol BV, Netherlands.

 

Performance increase with Lianol®

The unfavorable effect of the Negative Energy Balance on pig fertility and performance has been studied in depth and is largely documented in multiple academic circles.  Various forms of metabolic stress reduce the capacity of the liver cells to produce its normal endocrine metabolic peptides and related functions.  Low levels hereof can cause impaired fertility, retarded growth, impaired feed conversion and reduced immunity.  Lianol® administration supports the capacity of the liver to produce the necessary and needed physiological metabolic peptides.  All this results in a better natural immunity, enhanced natural heat, shorter weaning to insemination period and reduced number of empty days in sows, all inducing a better and restored liver function and metabolism.

 

More piglets, more benefit

With the benefits of Lianol® use in sows confirmed, the effect on the piglets was also studied.  It was found that the litters of Lianol® treated sows were not only larger, they also produced more weaned piglets and mortality levels were considerably lower than untreated sows.  Detailed results will be presented at the International Porcine Veterinary Society (IPVS) 2010, Vancouver.

 

Range addition

The combination of these findings with improved piglet immunity levels, higher milk production in sows, optimal standing heat, less empty days and even an increased boar libido and higher seamen quality was convincing enough for Huvepharma to include Lianol® in its broad world-wide available product range and to provide these product benefits to customers.  Next to the obtained results in pig production, Huvepharma is supporting research to develop use of Lianol® for other species.

 

 

 

Lianol® brand is owned by Ardol BV, Netherlands